FTLF

FitLife Brands, Inc.

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

FitLife Brands, Inc. (FTLF) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
B-
Factor Score 3.1 / 5.0
Growth
B
Factor Score 3.2 / 5.0
Profitability
B
Factor Score 3.3 / 5.0
Momentum
C-
Factor Score 2.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 13.4
EV / EBITDA 8.3
Rev Growth YoY 64.6%
Gross Margin 37.6%
Price Return 3M -25.6%
Price Return 12M -55.2%
Catalyst Signal 0.00
Market Cap $78.1M
TTM Revenue $101.3M
Price / Sales 0.8
ROE 14.1%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B- (3.1) B (3.2) B (3.3) C- (2.0) C+ (2.6) C+ (2.8)
2026-11-05 B (3.2) B (3.2) B (3.3) C (2.2) C+ (2.6) B- (2.9)
2026-10-29 B (3.2) B (3.3) B (3.3) C (2.4) C (2.5) B- (2.9)
2026-10-22 B (3.2) B (3.3) B (3.3) C (2.2) C (2.3) B- (2.9)
2026-10-15 B (3.2) B (3.3) B (3.3) C- (2.1) C (2.4) B- (2.9)
Page 1 of 8
…